# Genmab (GMAB) — Overview

GMAB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/gmab

## Price

Last close $37.82 on Oct 15, 2026. 52-week range $23.85 – $38.48.

## Company profile

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $4.1B |
| Revenue (quarter) | $1.2B |
| Revenue growth (year over year) | 24.86% |
| Gross profit (trailing twelve months) | $3.8B |
| Gross margin | 93.03% |
| Net income (trailing twelve months) | $788.0M |
| Net income (quarter) | $303.0M |
| Net income growth (year over year) | -9.82% |
| Net margin | 19.08% |
| Return on equity | 14.00% |
| EPS (trailing twelve months) | $1.28 |
| Book value per share | $9.55 |
| P/E (trailing twelve months) | 30.0 |
| Price to book | 4.0 |
| Debt to assets | 52.40% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Genmab (GMAB) profitable?

Yes. Genmab earned $788.0M in net income over the trailing twelve months, a net margin of 19.08%.

### How much revenue does Genmab (GMAB) make?

Genmab generated $4.1B in revenue over the trailing twelve months, up 24.86% year over year.

### What is GMAB's P/E ratio?

Genmab trades at 30.0 times trailing twelve-month earnings, on an EPS of $1.28.

### How do I buy stock in Genmab (GMAB)?

GMAB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).